US7150982B2
(en)
|
1991-09-09 |
2006-12-19 |
Third Wave Technologies, Inc. |
RNA detection assays
|
US6949367B1
(en)
*
|
1998-04-03 |
2005-09-27 |
Epoch Pharmaceuticals, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US6127121A
(en)
*
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US7045610B2
(en)
*
|
1998-04-03 |
2006-05-16 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
US7118860B2
(en)
*
|
1999-10-29 |
2006-10-10 |
Stratagene California |
Methods for detection of a target nucleic acid by capture
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
EP1944310A3
(de)
*
|
2000-03-01 |
2008-08-06 |
Epoch Biosciences, Inc. |
Modifizierte Oligonukleotide zur Erkennung von Fehlanpassungen
|
DE60142828D1
(de)
*
|
2000-03-01 |
2010-09-30 |
Epoch Biosciences Inc |
Modifizierte oligonukleotide zur unterscheidung von fehlpaarungen
|
US7238795B2
(en)
*
|
2000-08-03 |
2007-07-03 |
Roche Molecular Systems, Inc. |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
JP2005508196A
(ja)
*
|
2001-11-07 |
2005-03-31 |
アプレラ コーポレイション |
核酸分析の汎用ヌクレオチド
|
WO2003045310A2
(en)
|
2001-11-21 |
2003-06-05 |
Applera Corporation |
Digital assay
|
WO2003065146A2
(en)
|
2002-01-25 |
2003-08-07 |
Applera Corporation |
Methods for placing, accepting, and filling orders for products and services
|
US6818420B2
(en)
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
WO2004046387A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for analysis of regulatory sequences
|
US7297780B2
(en)
*
|
2003-01-06 |
2007-11-20 |
Third Wave Technologies, Inc. |
Reactive functional groups for preparation of modified nucleic acid
|
CN105596356A
(zh)
*
|
2003-01-14 |
2016-05-25 |
吉里德科学公司 |
用于联合抗病毒治疗的组合物和方法
|
US7429596B2
(en)
*
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
JP2007500727A
(ja)
*
|
2003-07-30 |
2007-01-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のための核酸塩基ホスホネートアナログ
|
US20050074799A1
(en)
*
|
2003-08-15 |
2005-04-07 |
Affymetrix, Inc. |
Use of guanine analogs in high-complexity genotyping
|
ES2529256T3
(es)
*
|
2003-10-28 |
2015-02-18 |
Epoch Biosciences, Inc. |
Sondas fluorescentes para la detección de ADN mediante hibridación con una sensibilidad mejorada y baja señal de fondo
|
US7439341B2
(en)
|
2003-11-14 |
2008-10-21 |
Integrated Dna Technologies, Inc. |
Fluorescence quenching azo dyes, their methods of preparation and use
|
ES2319648T3
(es)
*
|
2003-11-20 |
2009-05-11 |
Exiqon A/S |
Composicion atenuadora que comprende restos de antraquinona.
|
US7462451B2
(en)
*
|
2004-04-26 |
2008-12-09 |
Third Wave Technologies, Inc. |
Compositions for modifying nucleic acids
|
WO2006016978A1
(en)
*
|
2004-06-30 |
2006-02-16 |
Applera Corporation |
Analog probe complexes
|
US20060288444A1
(en)
*
|
2004-08-13 |
2006-12-21 |
Mccarroll Robert |
Soybean polymorphisms and methods of genotyping
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
US20060292586A1
(en)
*
|
2004-12-17 |
2006-12-28 |
Schroth Gary P |
ID-tag complexes, arrays, and methods of use thereof
|
US20060166238A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Ramsing Niels B |
Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
|
EP2813581B1
(de)
|
2005-01-06 |
2018-06-27 |
Applied Biosystems, LLC |
Verwendung von Polypeptiden mit Nukleinsäurebindungsaktivität in Verfahren schneller Nukleinsäurenamplifikation
|
US20060153745A1
(en)
*
|
2005-01-11 |
2006-07-13 |
Applera Corporation |
Fluid processing device for oligonucleotide synthesis and analysis
|
KR100682923B1
(ko)
|
2005-01-22 |
2007-02-15 |
삼성전자주식회사 |
허들 dna와 인공적인 미스매치가 도입된 프로브를이용한 단일 염기 미스매치에 대한 구별 향상 방법
|
EP1860115A4
(de)
*
|
2005-02-28 |
2010-09-22 |
Tokyo Inst Tech |
Oligonukleotidderivat, sonde zum aufspüren eines gens und dna-chip
|
JP2008545659A
(ja)
|
2005-05-20 |
2008-12-18 |
インテグレイテッド ディーエヌエイ テクノロジーズ インコーポレイテッド |
オリゴヌクレオチドを標識する化合物及び方法
|
US20090130666A1
(en)
*
|
2005-05-27 |
2009-05-21 |
Applera Corporation |
Cytometric system including nucleic acid sequence amplification, and method
|
US20060286590A1
(en)
*
|
2005-06-20 |
2006-12-21 |
Applera Corporation. |
Cis-regulatory modules
|
US7892795B2
(en)
*
|
2005-08-02 |
2011-02-22 |
Focus Diagnostics, Inc. |
Methods and compositions for detecting BK virus
|
US20070059713A1
(en)
|
2005-09-09 |
2007-03-15 |
Lee Jun E |
SSB-DNA polymerase fusion proteins
|
WO2007041201A2
(en)
|
2005-10-03 |
2007-04-12 |
Applera Corporation |
Compositions, methods, and kits for amplifying nucleic acids
|
EP1994182B1
(de)
|
2006-03-15 |
2019-05-29 |
Siemens Healthcare Diagnostics Inc. |
Abgleit-nucleobase-analoga
|
EP2557080A1
(de)
|
2006-04-04 |
2013-02-13 |
The Regents of The University of California |
Verfahren zur Identifizierung von PI3-Kinase-Antagonisten
|
MX2008014005A
(es)
|
2006-05-03 |
2009-01-27 |
Baltic Technology Dev Ltd |
Agentes antisentido que combinan un oligonucleotido modificado con base fuertemente unida y nucleasa artificial.
|
PL2018184T3
(pl)
|
2006-05-17 |
2013-12-31 |
The Ludwig Institute For Cancer Res |
Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
|
WO2008002920A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Epoch Biosciences, Inc. |
Methods for generating target nucleic acid sequences
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
AU2007281535A1
(en)
|
2006-08-01 |
2008-02-07 |
Applied Biosystems, Llc. |
Detection of analytes and nucleic acids
|
JPWO2008018305A1
(ja)
*
|
2006-08-08 |
2009-12-24 |
アークレイ株式会社 |
変異の検出方法およびそれに用いるキット
|
US20080083042A1
(en)
*
|
2006-08-14 |
2008-04-03 |
David Butruille |
Maize polymorphisms and methods of genotyping
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
US9938641B2
(en)
*
|
2006-12-18 |
2018-04-10 |
Fluidigm Corporation |
Selection of aptamers based on geometry
|
EP2195452B1
(de)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
WO2009067632A1
(en)
*
|
2007-11-20 |
2009-05-28 |
Applied Biosystems Inc. |
Method of sequencing nucleic acids using elaborated nucleotide phosphorothiolate compounds
|
WO2009067628A1
(en)
*
|
2007-11-20 |
2009-05-28 |
Applied Biosystems Inc. |
Reversible di-nucleotide terminator sequencing
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
MX2010007418A
(es)
|
2008-01-04 |
2010-11-12 |
Intellikine Inc |
Ciertas entidades quimicas, composiciones y metodos.
|
WO2009114874A2
(en)
*
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
WO2010006072A2
(en)
|
2008-07-08 |
2010-01-14 |
The Regents Of The University Of California |
Mtor modulators and uses thereof
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン, エルエルシー |
キナーゼインヒビターおよび使用方法
|
WO2010030716A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Igor Kutyavin |
Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン, エルエルシー |
複素環キナーゼ阻害剤
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン, エルエルシー |
複素環式化合物およびその使用
|
EP3597657B1
(de)
|
2009-05-21 |
2021-09-01 |
Siemens Healthcare Diagnostics Inc. |
Universaletiketten mit nichtnatürlichen nukleobasen
|
EP2435470A4
(de)
|
2009-05-26 |
2013-05-29 |
Agency Science Tech & Res |
Muteine der pyrrolin-5-carboxylat-reductase 1
|
WO2011037802A2
(en)
*
|
2009-09-28 |
2011-03-31 |
Igor Kutyavin |
Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
US20110151457A1
(en)
|
2009-12-22 |
2011-06-23 |
Elitech Holding B.V. |
Hypertheromostable endonuclease iv substrate probe
|
WO2011120049A1
(en)
|
2010-03-26 |
2011-09-29 |
Integrated Dna Technologies, Inc. |
Methods for enhancing nucleic acid hybridization
|
US9506057B2
(en)
|
2010-03-26 |
2016-11-29 |
Integrated Dna Technologies, Inc. |
Modifications for antisense compounds
|
US8604032B2
(en)
|
2010-05-21 |
2013-12-10 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
US10127349B2
(en)
|
2010-07-16 |
2018-11-13 |
Elitechgroup B.V. |
Method of producing oligomer affinity pairs
|
JP6053684B2
(ja)
|
2010-09-07 |
2016-12-27 |
インテグレイテツド・デイー・エヌ・エイ・テクノロジーズ・インコーポレイテツド |
アンチセンス化合物の修飾
|
EP2637669A4
(de)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclische verbindungen und ihre verwendung
|
CN103648499B
(zh)
|
2011-01-10 |
2017-02-15 |
无限药品股份有限公司 |
用于制备异喹啉酮的方法及异喹啉酮的固体形式
|
AR085397A1
(es)
|
2011-02-23 |
2013-09-25 |
Intellikine Inc |
Combinacion de inhibidores de quinasa y sus usos
|
WO2012129547A1
(en)
|
2011-03-23 |
2012-09-27 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
EP2714939B1
(de)
|
2011-05-24 |
2015-04-15 |
Elitech Holding B.V. |
Nachweis von methicillin-resistentem staphylococcus aureus
|
WO2012178187A1
(en)
|
2011-06-23 |
2012-12-27 |
Paul Yager |
Reagent patterning in capillarity-based analyzers and associated systems and methods
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
AU2012284091B2
(en)
|
2011-07-19 |
2015-11-12 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
JP6342805B2
(ja)
|
2011-09-02 |
2018-06-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
置換ピラゾロ[3,4−d]ピリミジンおよびその用途
|
CA3107640A1
(en)
|
2011-12-22 |
2013-06-27 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof and their use in ameliorating or treating a disease or condition associated with viral infections
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
WO2014015098A1
(en)
|
2012-07-18 |
2014-01-23 |
Siemens Healthcare Diagnostics Inc. |
A method of normalizing biological samples
|
RU2015115631A
(ru)
|
2012-09-26 |
2016-11-20 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Модулирование ire1
|
WO2014116756A1
(en)
|
2013-01-22 |
2014-07-31 |
University Of Washington Through Its Center For Commercialization |
Sequential delivery of fluid volumes and associated devices, systems and methods
|
WO2014164479A1
(en)
|
2013-03-11 |
2014-10-09 |
Elitech Holding B.V. |
Methods for true isothermal strand displacement amplification
|
US10590474B2
(en)
|
2013-03-11 |
2020-03-17 |
Elitechgroup B.V. |
Methods for true isothermal strand displacement amplification
|
US10975423B2
(en)
|
2013-03-11 |
2021-04-13 |
Elitechgroup, Inc. |
Methods for true isothermal strand displacement amplification
|
US9169256B2
(en)
|
2013-03-13 |
2015-10-27 |
Elitechgroup B.V. |
Artificial nucleic acids
|
BR112015022141A2
(pt)
|
2013-03-14 |
2017-08-29 |
Shire Human Genetic Therapies |
Método de quantificação de eficiência de capeamento de mrna, kit e método de fabricação de mrna
|
WO2014159063A1
(en)
|
2013-03-14 |
2014-10-02 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
CA2903487A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Quantitative assessment for cap efficiency of messenger rna
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
ES2654631T3
(es)
|
2013-05-13 |
2018-02-14 |
Elitechgroup B.V. |
PCR digital en gotas con sondas cortas de ranura menor
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX2021012208A
(es)
|
2013-10-04 |
2023-01-19 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos.
|
CA2943075C
(en)
|
2014-03-19 |
2023-02-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
EP3201356A1
(de)
|
2014-10-03 |
2017-08-09 |
Life Technologies Corporation |
Genetische sequenzüberprüfungszusammensetzungen, verfahren und kits
|
WO2016090165A1
(en)
|
2014-12-03 |
2016-06-09 |
Life Technologies Corporation |
Charged reactive oligomers
|
JP2017538419A
(ja)
|
2014-12-12 |
2017-12-28 |
エリテックグループ・ベスローテン・フェンノートシャップElitechgroup B.V. |
抗生物質耐性菌を検出するための方法および組成物
|
WO2016094607A2
(en)
|
2014-12-12 |
2016-06-16 |
Elitechgroup B.V. |
Methods and compositions for detecting antibiotic resistant bacteria
|
US10913944B2
(en)
|
2015-01-12 |
2021-02-09 |
Life Technologies Corporation |
Methods, systems and compositions thereof for nucleic acid library quality control and quantification
|
US10160761B2
(en)
|
2015-09-14 |
2018-12-25 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
|
US10865396B2
(en)
|
2015-10-29 |
2020-12-15 |
Temple University—Of the Commonwealth System of Higher Education |
Modification of 3′ terminal ends of nucleic acids by DNA polymerase theta
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP7054681B2
(ja)
|
2016-06-24 |
2022-04-14 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
組合せ療法
|
WO2018162986A2
(en)
|
2017-03-09 |
2018-09-13 |
Elitechgroup B.V. |
Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
|
ES2909351T3
(es)
|
2017-08-17 |
2022-05-06 |
Elitechgroup Inc |
Quencheres estabilizadores de fluorescencia dúplex para sondas de ácidos nucleicos
|
US10724017B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
|
US10689629B1
(en)
|
2017-12-06 |
2020-06-23 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands
|
US10724083B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands
|
CA3095292A1
(en)
|
2018-04-02 |
2019-10-10 |
Progenity, Inc. |
Methods, systems, and compositions for counting nucleic acid molecules
|
WO2019231617A1
(en)
|
2018-05-29 |
2019-12-05 |
Elitechgroup, Inc. |
Carborhodamine compounds and methods of preparation thereof
|
WO2020092268A2
(en)
*
|
2018-10-29 |
2020-05-07 |
Kutyavin Igor V |
Thermokinetically balanced isothermal amplification of nucleic acid sequences
|
WO2020206170A1
(en)
|
2019-04-02 |
2020-10-08 |
Progenity, Inc. |
Methods, systems, and compositions for counting nucleic acid molecules
|
WO2021080629A1
(en)
|
2019-10-23 |
2021-04-29 |
Elitechgroup, Inc. |
Methods for true isothermal strand displacement amplification
|
JP2023543424A
(ja)
|
2020-09-21 |
2023-10-16 |
ビオラ・セラピューティクス・インコーポレイテッド |
無細胞dnaを単離するための組成物および方法
|
WO2022256597A1
(en)
|
2021-06-04 |
2022-12-08 |
Translate Bio, Inc. |
Assay for quantitative assessment of mrna capping efficiency
|